Skip to main content
SpringerLink
Log in

Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3

  • Research Article
  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

Organic anion transporter 3 (OAT3) plays a vital role in removing a broad variety of anionic drugs from kidney, thus avoiding their possible toxicity in the body. We earlier established that activation of protein kinase C (PKC) enhances OAT3 ubiquitination, which promotes OAT3 internalization from the cell plasma membrane to intracellular endosomes and consequent degradation. As a result, OAT3 expression and transport activity are reduced. In the current study, we discovered that protein kinase A (PKA) had an opposite effect to PKC on the regulation of OAT3. We showed that activation of PKA by Bt2-cAMP stimulated OAT3 transport activity, which was largely caused by an enhanced plasma membrane expression of the transporter, kinetically reflected as an augmented maximal transport velocity Vmax without notable alteration in substrate-binding affinity Km. Additionally, we showed that PKA activation accelerated the rate of OAT3 recycling from intracellular compartments to the plasma membrane and decelerated the rate of OAT3 degradation. We further showed that OAT3 is subjected to post-translational modification by SUMO-2 and SUMO-3 not by SUMO-1. PKA activation enhanced OAT3 SUMOylation, which was accompanied by a reduced OAT3 ubiquitination. Finally, insulin-like growth factor 1 significantly stimulated OAT3 transport activity and SUMOylation through PKA signaling pathway. In conclusion, this is the first demonstration that PKA stimulated OAT3 expression and transport activity by altering the trafficking kinetics of OAT3 possibly through the crosstalk between SUMOylation and ubiquitination. Our studies are consistent with a remote sensing and signaling model for transporters (Wu et al. in Mol Pharmacol. 79(5):795–805, 2011).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. You G. Structure, function, and regulation of renal organic anion transporters. Med Res Rev. 2002;22(6):602–16. https://doi.org/10.1002/med.10019.

    Article  CAS  PubMed  Google Scholar 

  2. Srimaroeng C, Perry JL, Pritchard JB. Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica. 2008;38(7–8):889–935. https://doi.org/10.1080/00498250801927435.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Dantzler WH, Wright SH. The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. Biochim Biophys Acta. 2003;1618(2):185–93.

    Article  CAS  Google Scholar 

  4. VanWert AL, Gionfriddo MR, Sweet DH. Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos. 2010;31(1):1–71. https://doi.org/10.1002/bdd.693.

    Article  CAS  PubMed  Google Scholar 

  5. Ahn SY, Nigam SK. Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol. 2009;76(3):481–90. https://doi.org/10.1124/mol.109.056564.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Terada T, Inui K. Gene expression and regulation of drug transporters in the intestine and kidney. Biochem Pharmacol. 2007;73(3):440–9. https://doi.org/10.1016/j.bcp.2006.10.010.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang Q, Hong M, Duan P, Pan Z, Ma J, You G. Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway. J Biol Chem. 2008;283(47):32570–9. https://doi.org/10.1074/jbc.M800298200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zhang Q, Pan Z, You G. Regulation of human organic anion transporter 4 by protein kinase C and NHERF-1: altering the endocytosis of the transporter. Pharm Res. 2010;27(4):589–96. https://doi.org/10.1007/s11095-009-9983-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhang Q, Suh W, Pan Z, You G. Short-term and long-term effects of protein kinase C on the trafficking and stability of human organic anion transporter 3. Int J Biochem Mol Biol. 2012;3(2):242–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Xu D, Zhang J, Zhang Q, Fan Y, Liu C, You G. PKC/Nedd4-2 signaling pathway regulates the cell surface expression of drug transporter hOAT1. Drug Metab Dispos. 2017;45(8):887–95. https://doi.org/10.1124/dmd.117.075861.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010;11(12):861–71. https://doi.org/10.1038/nrm3011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ulrich HD. The fast-growing business of SUMO chains. Mol Cell. 2008;32(3):301–5. https://doi.org/10.1016/j.molcel.2008.10.010.

    Article  CAS  PubMed  Google Scholar 

  13. Plant LD, Dementieva IS, Kollewe A, Olikara S, Marks JD, Goldstein SA. One SUMO is sufficient to silence the dimeric potassium channel K2P1. Proc Natl Acad Sci U S A. 2010;107(23):10743–8. https://doi.org/10.1073/pnas.1004712107.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Rajan S, Plant LD, Rabin ML, Butler MH, Goldstein SA. Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell. 2005;121(1):37–47. https://doi.org/10.1016/j.cell.2005.01.019.

    Article  CAS  PubMed  Google Scholar 

  15. Rajan S, Dickson LM, Mathew E, Orr CM, Ellenbroek JH, Philipson LH, et al. Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic beta-cells via protein kinase A. Mol Metab. 2015;4(4):265–76. https://doi.org/10.1016/j.molmet.2015.01.010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kang JS, Saunier EF, Akhurst RJ, Derynck R. The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol. 2008;10(6):654–64. https://doi.org/10.1038/ncb1728.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tang Z, El Far O, Betz H, Scheschonka A. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. J Biol Chem. 2005;280(46):38153–9. https://doi.org/10.1074/jbc.M508168200.

    Article  CAS  PubMed  Google Scholar 

  18. Minami S, Ito K, Honma M, Ikebuchi Y, Anzai N, Kanai Y, et al. Posttranslational regulation of Abcc2 expression by SUMOylation system. Am J Physiol Gastrointest Liver Physiol. 2009;296(2):G406–13. https://doi.org/10.1152/ajpgi.90309.2008.

    Article  CAS  PubMed  Google Scholar 

  19. Giorgino F, de Robertis O, Laviola L, Montrone C, Perrini S, McCowen KC, et al. The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc Natl Acad Sci U S A. 2000;97(3):1125–30.

    Article  CAS  Google Scholar 

  20. Ulrich HD. Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol. 2005;15(10):525–32. https://doi.org/10.1016/j.tcb.2005.08.002.

    Article  CAS  PubMed  Google Scholar 

  21. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell. 1998;2(2):233–9.

    Article  CAS  Google Scholar 

  22. Duan P, Li S, You G. Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A. Int J Biochem Mol Biol. 2012;3(3):322–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Barros SA, Srimaroeng C, Perry JL, Walden R, Dembla-Rajpal N, Sweet DH, et al. Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport. J Biol Chem. 2009;284(5):2672–9. https://doi.org/10.1074/jbc.M808078200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Soodvilai S, Chatsudthipong V, Evans KK, Wright SH, Dantzler WH. Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. Am J Physiol Ren Physiol. 2004;287(5):F1021–9. https://doi.org/10.1152/ajprenal.00080.2004.

    Article  CAS  Google Scholar 

  25. Subramaniam S, Shahani N, Strelau J, Laliberte C, Brandt R, Kaplan D, et al. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci. 2005;25(11):2838–52. https://doi.org/10.1523/JNEUROSCI.5060-04.2005.

    Article  CAS  PubMed  Google Scholar 

  26. Wang H, You G. SGK1/Nedd4-2 signaling pathway regulates the activity of human organic anion transporters 3. Biopharm Drug Dispos. 2017;38(8):449–57. https://doi.org/10.1002/bdd.2085.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wang H, Xu D, Toh MF, Pao AC, You G. Serum- and glucocorticoid-inducible kinase SGK2 regulates human organic anion transporters 4 via ubiquitin ligase Nedd4-2. Biochem Pharmacol. 2016;102:120–9. https://doi.org/10.1016/j.bcp.2015.11.024.

    Article  CAS  PubMed  Google Scholar 

  28. Zhang Q, Li S, Patterson C, You G. Lysine 48-linked polyubiquitination of organic anion transporter-1 is essential for its protein kinase C-regulated endocytosis. Mol Pharmacol. 2013;83(1):217–24. https://doi.org/10.1124/mol.112.082065.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Duan P, Li S, You G. Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: accelerating endocytosis of the transporter. Eur J Pharmacol. 2010;627(1–3):49–55. https://doi.org/10.1016/j.ejphar.2009.10.048.

    Article  CAS  PubMed  Google Scholar 

  30. Phatchawan A, Chutima S, Varanuj C, Anusorn L. Decreased renal organic anion transporter 3 expression in type 1 diabetic rats. Am J Med Sci. 2014;347(3):221–7. https://doi.org/10.1097/MAJ.0b013e3182831740.

    Article  PubMed  Google Scholar 

  31. Muller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 1998;17(1):61–70. https://doi.org/10.1093/emboj/17.1.61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Yang SH, Jaffray E, Senthinathan B, Hay RT, Sharrocks AD. SUMO and transcriptional repression: dynamic interactions between the MAP kinase and SUMO pathways. Cell Cycle. 2003;2(6):528–30. https://doi.org/10.4161/cc.2.6.597.

    Article  CAS  PubMed  Google Scholar 

  33. Hietakangas V, Ahlskog JK, Jakobsson AM, Hellesuo M, Sahlberg NM, Holmberg CI, et al. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol. 2003;23(8):2953–68.

    Article  CAS  Google Scholar 

  34. Bach LA, Hale LJ. Insulin-like growth factors and kidney disease. Am J Kidney Dis. 2015;65(2):327–36. https://doi.org/10.1053/j.ajkd.2014.05.024.

    Article  CAS  PubMed  Google Scholar 

  35. Yakar S, Adamo ML. Insulin-like growth factor 1 physiology: lessons from mouse models. Endocrinol Metab Clin N Am. 2012;41(2):231–47, v. https://doi.org/10.1016/j.ecl.2012.04.008.

    Article  CAS  Google Scholar 

  36. Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A, et al. Expert consensus document: a consensus on the medical treatment of acromegaly. Nat Rev Endocrinol. 2014;10(4):243–8. https://doi.org/10.1038/nrendo.2014.21.

    Article  CAS  PubMed  Google Scholar 

  37. Janecka A, Kolodziej-Rzepa M, Biesaga B. Clinical and molecular features of Laron syndrome, a genetic disorder protecting from cancer. In Vivo. 2016;30(4):375–81.

    CAS  PubMed  Google Scholar 

  38. Bang P, Polak M, Woelfle J, Houchard A, Group EIRS. Effectiveness. Safety of rhIGF-1 therapy in children: The European Increlex(R) Growth Forum Database Experience. Horm Res Paediatr. 2015;83(5):345–57. https://doi.org/10.1159/000371798.

    Article  CAS  PubMed  Google Scholar 

  39. Cohen J, Blethen S, Kuntze J, Smith SL, Lomax KG, Mathew PM. Managing the child with severe primary insulinlike growth factor-1 deficiency (IGFD): IGFD diagnosis and management. Drugs R D. 2014;14(1):25–9. https://doi.org/10.1007/s40268-014-0039-7.

  40. Wu W, Dnyanmote AV, Nigam SK. Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol. 2011;79(5):795–805. https://doi.org/10.1124/mol.110.070607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Bush KT, Wu W, Lun C, Nigam SK. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis. J Biol Chem. 2017;292(38):15789–803. https://doi.org/10.1074/jbc.M117.796516.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wu W, Jamshidi N, Eraly SA, Liu HC, Bush KT, Palsson BO, et al. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab Dispos. 2013;41(10):1825–34. https://doi.org/10.1124/dmd.113.052647.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Jorge A Iñiguez-Lluhí for his generous gifts of HA-tagged SUMO1, SUMO2, SUMO3, and Ubc9 plasmids.

Funding

This work was supported by grants (to Dr. Guofeng You) from National Institute of General Medical Sciences (R01-GM079123 and R01-GM097000).

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey, 08854, USA

    Haoxun Wang, Jinghui Zhang & Guofeng You

Authors
  1. Haoxun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinghui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guofeng You
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guofeng You.

Ethics declarations

Conflict of Interest

The authors have declared that there is no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Zhang, J. & You, G. Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3. AAPS J 21, 30 (2019). https://doi.org/10.1208/s12248-019-0303-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12248-019-0303-4

KEY WORDS

Search

Navigation